Despite recent therapeutic advances, pulmonary hypertension (PH) remains a fatal disease
due to the development of right ventricular (RV) failure. At present, no treatments targeted at …

Chronic thrombo-embolic pulmonary hypertension (CTEPH) develops in a subset of patients
after acute pulmonary embolism. In CTEPH, pulmonary vascular resistance, which is initially …

Chronic thromboembolic pulmonary hypertension (CTEPH) develops due to the
accumulation of blood clots in the lung vasculature that obstructs flow and increases …

Key points Right ventricle (RV) function is the most important determinant of survival and
quality of life in patients with chronic thromboembolic pulmonary hypertension (CTEPH). The …

This study aimed to construct an atlas of the cell landscape and comprehensively
characterize the cellular repertoire of the pulmonary endarterectomized tissues of patients …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and life-threatening
complication of pulmonary embolism. As existing animal models of CTEPH do not fully …

Background Chronic thromboembolic pulmonary hypertension (CTEPH) leads to right heart
failure. Pulmonary endarterectomy (PEA) or balloon pulmonary angioplasty (BPA) restore …

Abstract Purpose of Review Chronic thromboembolic pulmonary hypertension (CTEPH) is
an uncommon complication of acute pulmonary embolism (PE), in which the red, platelet …

Background Right ventricle failure (RVF) is associated with serious cardiac and pulmonary
diseases that contribute significantly to the morbidity and mortality of patients. Currently, the …

Microvascular disease is a contributor to persistent pulmonary hypertension in those with
chronic thromboembolic pulmonary hypertension (CTEPH). The heterogenous nature of the …